Newsroom

Thumbnail Podcast
News
A single vaccination that provides protection for many years – so far, this has rarely been possible with vaccines against respiratory pathogens. Regular booster shots are often necessary. Dr. Henning Jacobsen and Casper Silvis from the Helmholtz Centre for Infection Research (HZI) want to change that. As part of the ENDURIVAC project, they are developing a vaccine technology designed to provide long-lasting protection after just one dose. In this episode of the HZI podcast InFact, they explain how the technology works, why it is initially being used to develop a vaccine against RSV and whether booster shots could largely become unnecessary in the future.
23.09.2026
Group photo with three men in front of a wall with colorful dots
Story
Tonsillitis, bacterial pneumonia or a middle ear infection? For decades, we could easily treat infections like these with antibiotics. However, as bacteria increasingly display resistance to antimicrobial drugs, this status is being threatened. To safeguard us against a future without antibiotics, researchers at the Helmholtz Centre for Infection Research (HZI) are exploring new treatment strategies. In the department “Chemical Biology” led by Prof. Mark Brönstrup, they are developing a pathoblocker that neutralizes a disease-causing toxin of Staphylococcus aureus without affecting bacterial growth. By disarming the pathogen instead of killing it, this approach could reduce the evolutionary pressure that drives the emergence of antibiotic resistance.
22.09.2026
 Melanoma cell on a black background
News
The ability of cells to move and change their positions is essential for various processes in our bodies. Immune cells move to sites of action, epithelial cells migrate during wound closure and neurons wire up their axons for signal transmission over long distances, while in metastasis, cancer cells employ their motile machineries to spread throughout our bodies. A team around Prof. Klemens Rottner heading the Research Group “Molecular Cell Biology” at the Helmholtz Centre for Infection Research (HZI) has now shed new light on the central molecular interactions that accompany the formation of cytoskeletal networks at the forefront of migrating cells. Obtained insights pave the way for defining how such processes are changing in diseases and how they can potentially be modulated in the future. The results have just been published in the scientific journal Nature Communications.
21.09.2026
Fungus in the forest
News
The Helmholtz Centre for Infection Research (HZI) is once again coordinating an international research and exchange project in fungal research through “Mycobiomics 2.0”. The recently launched project is funded as a Marie Skłodowska-Curie Action (MSCA) under the EU’s Horizon Europe research framework program and has a total budget of nearly 1.8 million euros. Mycobiomics 2.0 builds on the successful predecessor projects “GoMyTri” (2014–2018) and “Mycobiomics” (2021–2025), which were also coordinated by the HZI. The project focuses on the discovery of new anti-infective compounds to combat the increasing spread of antimicrobial resistance.
18.09.2026
Groundbreaking ceremony for the new research building of HIPS
News
On September 17, 2026, the grand opening of the first expansion building of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) took place on the campus of Saarland University. As part of the event, the groundbreaking ceremony for a second expansion building also occurred, with completion planned for 2029. Together with the existing building, the two new buildings are intended to provide space for up to 350 researchers to discover and develop new active ingredients to combat infectious diseases and beyond. The effective area of the two new buildings totals 6,000 m², distributed across laboratory, office, and seminar spaces. The construction projects are being funded with a total of 89.5 million euros, with 20 million provided by the federal government and the remaining funding coming from the state of Saarland and the European Union. The launch of this unprecedented expansion process at a Helmholtz Institute was an expansion resolution passed by the Budget Committee of the Bundestag in December 2020. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.
17.09.2026
Flock of sheep in warm morning light on a pasture.
News
A highly contagious viral disease, sheeppox spreads rapidly and can affect large portions of a flock in a short time. The disease is particularly dangerous because it can cause very high mortality rates, especially in young animals, and dramatically reduces productivity by damaging wool, meat and milk yields. By extracting DNA from a range of ancient animal remains, an international team of geneticists, historians, virologists, protein chemists and conservators, has been able to uncover more than 3,500 years of history of the sheeppox virus (SPPV). The Helmholtz Institute for One Health (HIOH), a site of the Helmholtz Centre for Infection Research (HZI), took part to the study led by University College Dublin (UCD).
08.09.2026

HZI in the media

Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig erwartet insgesamt einen typischen

12.11.2026
|
Wiesbadener Kurier

... Technischen Universität Braunschweig, Forschungsgruppenleiter am Helmholtz Zentrum für Infektionsforschung.

 

Nach seiner Promotion über ...

09.11.2026
|
Radio38

WDR am 05.11.2026: Vitamine sind lebenswichtig. Viele greifen deshalb zu Kapseln, Pulvern und Brausetabletten, um mit einer Extraportion nachzuhelfen.

 

Das Geschäft boomt: Hersteller versprechen mehr Energie, ein stärkeres Immunsystem, gesünderes Altern und Schutz vor Krankheiten

06.11.2026
|
ARD Mediathek

Jörg Vogel, Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung und Sprecher der Leopoldina-Arbeitsgruppe RNA-basierte ...

04.11.2026
|
Tagesschau

... Team der MHH beteiligen sich das Helmholtz-Zentrum für Infektionsforschung, das Fraunhofer-Institut für Toxikologie und ...

04.11.2026
|
Deutsches Ärzteblatt

... leitete er eine Forschungsgruppe am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI) in Würzburg.

 

Vorbeugen - ...

02.11.2026
|
Management & Krankenhaus

"Trump ist eine Bedrohung für die Demokratie und Freiheit. Eine Rückkehr in die USA ist beruflich keine Option mehr", so Biologin Dr. Elsa Anderson. Forschenden droht in den USA in der zweiten Amtszeit von Donald Trump der Verlust ihrer wissenschaftlichen Freiheit, sie suchen des

02.11.2026
|
arte

... nach dem Saarland benannt.

 

Seit gut drei Jahren läuft das vom Helmholtz-Institut für Pharmazeutische Forschung ...

02.11.2026
|
Tagesschau

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI) und Mitglied der Ständigen Impfkommission ...

30.10.2026
|
Focus Online

von Mikroorganismen und Zellkulturen und des Helmholtz-Zentrums für Infektionsforschung zwei bislang unbekannte Naturstoffe entdeckt. Die

30.10.2026
|
Bionity.COM

Researchers at the Helmholtz Centre for Infection Research (HZI) and its Saarland University partner site, the Helmholtz Institute for

27.10.2026
|
Scienmag Science Magazine

experimental and modeling study led by scientists at the Helmholtz Centre for Infection Research in Braunschweig. The researchers found that

26.10.2026
|
Bioengineer.org

Register now for the HZI newsletter